SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000819050-22-000157
Filing Date
2022-09-20
Accepted
2022-09-20 16:48:21
Documents
13
Period of Report
2022-09-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K frtx-20220920.htm   iXBRL 8-K 33562
5 frtx-20220920_g1.jpg GRAPHIC 29102
  Complete submission text file 0000819050-22-000157.txt   237542

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT frtx-20220920.xsd EX-101.SCH 1903
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT frtx-20220920_lab.xml EX-101.LAB 25154
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT frtx-20220920_pre.xml EX-101.PRE 13050
7 EXTRACTED XBRL INSTANCE DOCUMENT frtx-20220920_htm.xml XML 11264
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 221254200
SIC: 2836 Biological Products, (No Diagnostic Substances)